Insiders · Profile

Murphy Matthew B.

General Counsel at Nautilus Biotechnology. Filing since 13 Aug 2021. CIK 0001865778

Company
Date
Role
Action
Shares
Amount
Of holding
4 Sep 2025
General Counsel
Bought
20,000
$12.86K
36.9%
15 Aug 2022
General Counsel
Bought
7,500
$21.31K
16.1%
12 Aug 2022
General Counsel
Bought
2,500
$7.13K
5.7%
13 Aug 2021
General Counsel
Bought
5,000
$37.81K
17.2%
4 decisions on file.